VISTA, CA – June 15, 2026 – Leica Biosystems, a Danaher firm and a worldwide chief in end-to-end anatomic and digital pathology options, is increasing the supply of its
Aperio GT Elite digital scanner into the EMEA (Europe, Center East & Africa) area following its March US launch. Designed for high-throughput workflows, the system helps laboratories scale digital pathology adoption by way of quicker scanning and built-in AI-powered high quality management. The enlargement displays rising market demand for extra related digital and computational pathology workflows in analysis environments.
Picture Credit score: Leica Biosystems
The Aperio GT Elite answer is designed for high-throughput digital pathology scanning, serving to laboratories enhance workflow effectivity and scale back guide intervention. Embedded SmartScan™ expertise makes use of barcode-driven intelligence to use optimum scan settings routinely, enabling combined slides to be processed seamlessly in a single run with out guide sorting or changes. With speeds of as much as 103 slides per hour and slide scan occasions as quick as 22 seconds per slide*, the system gives the automation and throughput required for routine, high-volume use, whereas serving to laboratories work with better confidence in outcomes.
“The sturdy market response following the US launch of the Aperio GT Elite answer, mixed with the rising demand for digital and AI-enabled pathology workflows, has accelerated our enlargement into EMEA,” stated Naveen Chandra, Vice President and Common Supervisor of Digital Pathology at Leica Biosystems. “As laboratories scale digital pathology adoption, they want options that mix throughput, workflow effectivity, and confidence in picture high quality. The Aperio GT Elite answer delivers high-throughput scanning with built-in high quality management as a part of Leica Biosystems’ broader digital pathology portfolio. With options spanning your complete anatomic pathology workflow, Leica Biosystems is uniquely positioned to assist laboratories streamline operations, scale back rescans, and allow digital pathology adoption at enterprise scale.”
When paired with
Aperio iQC software program, the Aperio GT Elite scanner brings AI‑powered high quality management instantly into the scanning workflow. The software program routinely detects widespread entire slide imaging artifacts and alerts customers whereas slides are nonetheless on the scanner, serving to tackle points earlier than expensive rework and time are required.
Leica Biosystems will showcase the Aperio GT Elite answer on Thursday, June 18, at sales space #26 through the European Congress on Digital Pathology 2026 (ECDP) in Graz, Austria. Attendees may have an unique alternative to expertise this industry-first system firsthand and discover the breadth of Leica Biosystems’ portfolio.
For extra data on the Aperio GT Elite answer and the total digital and computational portfolio from Leica Biosystems, click on
right here.
*15mm x 15mm @40x. For analysis use solely. Not to be used in diagnostic procedures.
About Leica Biosystems
Leica Biosystems is a most cancers diagnostics firm and a worldwide chief in end-to-end anatomic and digital pathology options. The corporate provides a complete product vary for every step within the pathology course of, from pattern preparation and marking to imaging and reporting. As the one firm to personal the total workflow from biopsy to analysis, Leica Biosystems is uniquely positioned to interrupt down the obstacles between every step. The corporate’s mission of ‘Advancing Most cancers Diagnostics, Bettering Lives’ is on the coronary heart of its company tradition. Leica Biosystems is proud to be a Danaher Company subsidiary. Study extra at
www.leicabiosystems.com.
About Danaher
Danaher is a number one international life sciences and diagnostics innovator, dedicated to accelerating the ability of science and expertise to enhance human well being. By our related ecosystem of industry-leading companies, we work aspect by aspect with prospects to unravel their most advanced scientific and medical challenges – serving to transfer improvements from discovery to supply quicker for sufferers who rely on them. Powered by the Danaher Enterprise System, our superior science and expertise and confirmed means to innovate assist allow quicker, extra correct diagnoses and scale back the time, price, and threat required to find, develop, and ship life-changing therapies. By steady enchancment and operational excellence, our roughly 60,000 associates worldwide are targeted on delivering lasting affect and bettering high quality of life world wide, whereas constructing a more healthy, extra sustainable tomorrow. Discover extra at
www.danaher.com.
